Industrial Alliance Securities analyst Blair Abernethy says that after attending the company’s annual user conference he feels positive about Descartes Systems Group (Descartes Systems Group Stock Quote, Chart, News: TSX:DSG, Nasadaq:DSGX), but cautions that this is not a year the Waterloo company will be shaking things up.
In a research update to clients today, Abernethy maintained his “Hold” rating and one-year price target of $23.00 on Descartes, implying a return of 1.1 per cent at the time of publication.
Abernethy says there were a couple key takeaways from the conference. The first is that he expects M&A to be the key revenue driver for the company, and that internally it is focused on “incremental” innovation, with a lot of focus on the integration of recently acquired products. Shares of Descartes have more than doubled since 2014, but the analyst says 2017 is not a year he expects any crazy upside.
“In our opinion, it is “steady as she goes” at Descartes this year, Abernethy says. “We don’t see anything transformative happening on the product or partner front, or anything highly disruptive or risky occurring on the horizon.”
Abernethy thinks Descartes will generate EBITDA of $78.5-million on revenue of $227.2-million in fiscal 2018. He expects these numbers will improve to EBITDA of $84.1-million on a topline of $240.4-million the following year.
Haywood Securities analyst Neal Gilmer raised his target for Auxly Cannabis Group (Auxly Cannabis Group Stock Quote, Chart, News, Analysts,… [Read More]
RBC Dominion Securities analyst Paul Treiber raised his target for CGI (CGI Stock Quote, Chart, News, Analysts, Financials TSX:GIB.A) to… [Read More]
Inflation is running above 3% in eight Canadian provinces, with Atlantic Canada facing some of the strongest price pressures as… [Read More]
National Bank Financial analyst Jaeme Gloyn lowered his target for goeasy (goeasy Stock Quote, Chart, News, Analysts, Financials TSX:GSY) to… [Read More]
Roth Capital Partners analyst Boobalan Pachaiyappan lowered his target on Gain Therapeutics (Gain Therapeutics Stock Quote, Chart, News, Analysts, Financials… [Read More]
WELLSTAR Technologies’ (WELLSTAR Technologies Corp. Stock Quote, Chart, News, Analysts, Financials TSXV:WSTR) first quarterly results as a public company exceeded… [Read More]